Cargando…
The Effectiveness and Value of Esketamine for the Management of Treatment-Resistant Depression: A Summary from the Institute for Clinical and Economic Review’s Midwest Comparative Effectiveness Public Advisory Council
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Academy of Managed Care Pharmacy
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10391009/ https://www.ncbi.nlm.nih.gov/pubmed/31880219 http://dx.doi.org/10.18553/jmcp.2020.26.1.16 |
| _version_ | 1785082604447334400 |
|---|---|
| author | Agboola, Foluso Atlas, Steven J. Touchette, Daniel R. Fazioli, Katherine Pearson, Steven D. |
| author_facet | Agboola, Foluso Atlas, Steven J. Touchette, Daniel R. Fazioli, Katherine Pearson, Steven D. |
| author_sort | Agboola, Foluso |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10391009 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | Academy of Managed Care Pharmacy |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-103910092023-08-02 The Effectiveness and Value of Esketamine for the Management of Treatment-Resistant Depression: A Summary from the Institute for Clinical and Economic Review’s Midwest Comparative Effectiveness Public Advisory Council Agboola, Foluso Atlas, Steven J. Touchette, Daniel R. Fazioli, Katherine Pearson, Steven D. J Manag Care Spec Pharm Perspectives on Value Academy of Managed Care Pharmacy 2020-01 /pmc/articles/PMC10391009/ /pubmed/31880219 http://dx.doi.org/10.18553/jmcp.2020.26.1.16 Text en Copyright © 2020, Academy of Managed Care Pharmacy. All rights reserved. https://creativecommons.org/licenses/by/4.0/This article is licensed under a Creative Commons Attribution 4.0 International License, which permits unrestricted use and redistribution provided that the original author and source are credited. |
| spellingShingle | Perspectives on Value Agboola, Foluso Atlas, Steven J. Touchette, Daniel R. Fazioli, Katherine Pearson, Steven D. The Effectiveness and Value of Esketamine for the Management of Treatment-Resistant Depression: A Summary from the Institute for Clinical and Economic Review’s Midwest Comparative Effectiveness Public Advisory Council |
| title | The Effectiveness and Value of Esketamine for the Management of Treatment-Resistant Depression: A Summary from the Institute for Clinical and Economic Review’s Midwest Comparative Effectiveness Public Advisory Council |
| title_full | The Effectiveness and Value of Esketamine for the Management of Treatment-Resistant Depression: A Summary from the Institute for Clinical and Economic Review’s Midwest Comparative Effectiveness Public Advisory Council |
| title_fullStr | The Effectiveness and Value of Esketamine for the Management of Treatment-Resistant Depression: A Summary from the Institute for Clinical and Economic Review’s Midwest Comparative Effectiveness Public Advisory Council |
| title_full_unstemmed | The Effectiveness and Value of Esketamine for the Management of Treatment-Resistant Depression: A Summary from the Institute for Clinical and Economic Review’s Midwest Comparative Effectiveness Public Advisory Council |
| title_short | The Effectiveness and Value of Esketamine for the Management of Treatment-Resistant Depression: A Summary from the Institute for Clinical and Economic Review’s Midwest Comparative Effectiveness Public Advisory Council |
| title_sort | effectiveness and value of esketamine for the management of treatment-resistant depression: a summary from the institute for clinical and economic review’s midwest comparative effectiveness public advisory council |
| topic | Perspectives on Value |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10391009/ https://www.ncbi.nlm.nih.gov/pubmed/31880219 http://dx.doi.org/10.18553/jmcp.2020.26.1.16 |
| work_keys_str_mv | AT agboolafoluso theeffectivenessandvalueofesketamineforthemanagementoftreatmentresistantdepressionasummaryfromtheinstituteforclinicalandeconomicreviewsmidwestcomparativeeffectivenesspublicadvisorycouncil AT atlasstevenj theeffectivenessandvalueofesketamineforthemanagementoftreatmentresistantdepressionasummaryfromtheinstituteforclinicalandeconomicreviewsmidwestcomparativeeffectivenesspublicadvisorycouncil AT touchettedanielr theeffectivenessandvalueofesketamineforthemanagementoftreatmentresistantdepressionasummaryfromtheinstituteforclinicalandeconomicreviewsmidwestcomparativeeffectivenesspublicadvisorycouncil AT faziolikatherine theeffectivenessandvalueofesketamineforthemanagementoftreatmentresistantdepressionasummaryfromtheinstituteforclinicalandeconomicreviewsmidwestcomparativeeffectivenesspublicadvisorycouncil AT pearsonstevend theeffectivenessandvalueofesketamineforthemanagementoftreatmentresistantdepressionasummaryfromtheinstituteforclinicalandeconomicreviewsmidwestcomparativeeffectivenesspublicadvisorycouncil AT agboolafoluso effectivenessandvalueofesketamineforthemanagementoftreatmentresistantdepressionasummaryfromtheinstituteforclinicalandeconomicreviewsmidwestcomparativeeffectivenesspublicadvisorycouncil AT atlasstevenj effectivenessandvalueofesketamineforthemanagementoftreatmentresistantdepressionasummaryfromtheinstituteforclinicalandeconomicreviewsmidwestcomparativeeffectivenesspublicadvisorycouncil AT touchettedanielr effectivenessandvalueofesketamineforthemanagementoftreatmentresistantdepressionasummaryfromtheinstituteforclinicalandeconomicreviewsmidwestcomparativeeffectivenesspublicadvisorycouncil AT faziolikatherine effectivenessandvalueofesketamineforthemanagementoftreatmentresistantdepressionasummaryfromtheinstituteforclinicalandeconomicreviewsmidwestcomparativeeffectivenesspublicadvisorycouncil AT pearsonstevend effectivenessandvalueofesketamineforthemanagementoftreatmentresistantdepressionasummaryfromtheinstituteforclinicalandeconomicreviewsmidwestcomparativeeffectivenesspublicadvisorycouncil |